Groove Botanicals Inc (GRVE)

Healthcare | Drug Manufacturers Specialty Generic
Income Statement (Quarterly) 2025-06-30 2024-12-31 2024-09-30 2024-06-30
Revenue 0 0 0 0
Cost of Revenue 0 0 0 0
Gross Profit 0 0 0 0
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 38,170 33,031 18,332 36,539
Operating Expenses 38,170 33,031 29,833 36,539
Operating Income -38,170 -33,031 -29,833 -36,539
Interest Expense 0 0 0 0
Income Before Tax -38,170 -33,031 -29,833 -36,539
Income Tax Expense 0 0 0 0
Net Income -38,170 -33,031 -29,833 -36,539
Per Share
EPS 0.00 0.00 0.00 0.00
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Revenue 0 0 1,180 8,052
Cost of Revenue 0 0 0 0
Gross Profit 0 0 1,180 8,052
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 73,087 266,581 175,514 545,517
Operating Expenses 130,834 266,581 175,514 545,517
Operating Income 0 -266,581 -175,510 -537,460
Interest Expense 0 6,750 96,538 72,708
Income Before Tax -349,304 -202,089 -120,726 -547,671
Income Tax Expense 0 0 -157 0
Net Income -349,304 -202,089 -120,726 -547,671
Per Share
EPS -0.01 -0.01 0.00 -0.01
EPS Diluted 0.00 0.00 0.00 0.00
Balance Sheet (Quarterly) 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Assets
Cash and Cash Equivalents 2,042 1,688 4,566 48,534
Short Term Investments 0 0 0 0
Net Receivables 0 0 25 251
Inventory 0 0 -25 0
Total Current Assets 4,520 2,142 5,048 48,785
Property Plant Equipment 0 0 0 0
Goodwill and Intangibles 0 0 0 0
Total Assets 4,520 2,142 5,048 48,785
Liabilities
Account Payables 68,608 91,172 37,754 247
Short Term Debt 0 0 90,000 233,013
Total Current Liabilities 1,114,381 762,699 443,346 354,243
Long Term Debt 0 0 0 0
Total Liabilities 1,114,381 762,699 443,346 354,243
Shareholders Equity
Retained Earnings -35,196,581 -34,847,277 -34,426,718 -34,358,466
Total Shareholders Equity -1,109,861 -760,557 -438,298 -305,459
Balance Sheet (Annual) 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Assets
Cash and Cash Equivalents 2,042 1,688 4,566 48,534
Short Term Investments 0 0 0 0
Net Receivables 0 0 25 251
Inventory 0 0 -25 0
Total Current Assets 4,520 2,142 5,048 48,785
Property Plant Equipment 0 0 0 0
Goodwill and Intangibles 0 0 0 0
Total Assets 4,520 2,142 5,048 48,785
Liabilities
Account Payables 68,608 91,172 37,754 247
Short Term Debt 0 0 90,000 233,013
Total Current Liabilities 1,114,381 762,699 443,346 354,243
Long Term Debt 0 0 0 0
Total Liabilities 1,114,381 762,699 443,346 354,243
Shareholders Equity
Retained Earnings -35,196,581 -34,847,277 -34,426,718 -34,358,466
Total Shareholders Equity -1,109,861 -760,557 -438,298 -305,459
Cash Flow Statement (Quarterly) 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Operating Activities
Net Income -130,834 -202,089 -120,726 -547,671
Depreciation & Amortization 0 0 0 0
Stock Based Compensation 0 0 14,000 0
Change in Working Capital 0 53,446 -3,094 7,896
Operating Cash Flow -107,422 -86,835 -115,403 -32,905
Investing Activities
Capital Expenditure 0 0 0 0
Investments 0 0 0 0
Investing Cash Flow 0 0 0 0
Financing Activities
Debt Repayment 0 -40,000 -150,000 -31,522
Common Stock Issued/Repurchased 0 20,000 42,963 105,050
Dividends Paid 0 0 0 0
Financing Cash Flow 107,776 83,957 51,535 73,528
Summary
Free Cash Flow -107,422 -86,835 -115,403 -32,905
Net Change in Cash 354 -2,878 -43,968 40,623
Cash Flow Statement (Annual) 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Operating Activities
Net Income -130,834 -202,089 -120,726 -547,671
Depreciation & Amortization 0 0 0 0
Stock Based Compensation 0 0 14,000 0
Change in Working Capital 0 53,446 -3,094 7,896
Operating Cash Flow -107,422 -86,835 -115,403 -32,905
Investing Activities
Capital Expenditure 0 0 0 0
Investments 0 0 0 0
Investing Cash Flow 0 0 0 0
Financing Activities
Debt Repayment 0 -40,000 -150,000 -31,522
Common Stock Issued/Repurchased 0 20,000 42,963 105,050
Dividends Paid 0 0 0 0
Financing Cash Flow 107,776 83,957 51,535 73,528
Summary
Free Cash Flow -107,422 -86,835 -115,403 -32,905
Net Change in Cash 354 -2,878 -43,968 40,623